Progranulin: A promising biomarker and therapeutic target for fibrotic diseases
Progranulin (PGRN), a multifunctional growth factor-like protein expressed by a variety of cell types, serves an important function in the physiologic and pathologic processes of fibrotic diseases, including wound healing and the inflammatory response. PGRN was discovered to inhibit pro-inflammation...
Saved in:
Main Authors: | Fan Yang (Author), Ming-Han Cheng (Author), Hai-Feng Pan (Author), Jian Gao (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progranulin as a Potential Therapeutic Target in Immune-Mediated Diseases
by: Lan YJ, et al.
Published: (2021) -
Therapeutic Targeting of Fibrotic Epithelial-Mesenchymal Transition-An Outstanding Challenge
by: Attila Fintha, et al.
Published: (2019) -
Progranulin Is Associated with Disease Activity in Patients with Rheumatoid Arthritis
by: Lucie Andrés Cerezo, et al.
Published: (2015) -
Prevention of LPS-Induced Acute Lung Injury in Mice by Progranulin
by: Zhongliang Guo, et al.
Published: (2012) -
Epac: A Promising Therapeutic Target for Vascular Diseases: A Review
by: Yunfeng Pan, et al.
Published: (2022)